Phase II study of S-1 chemotherapy in elderly patients with advanced non-small cell lung cancer harboring no EGFR gene mutatio
Not Applicable
Recruiting
- Conditions
- on-small cell lung cancer
- Registration Number
- JPRN-UMIN000005058
- Lead Sponsor
- Respiratory Center, Asahikawa Medical University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
Patients are excluded if they have; 1) severe concomitant diseases, 2) interstitial pneumonia, 3) NSCLC with EGFR gene mutations, 4) no measurable lesion.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Response rate.
- Secondary Outcome Measures
Name Time Method Disease control rate, overall survival, progression free survival, safety.